share_log

南华生物:西部证券股份有限公司关于南华生物医药股份有限公司2023年度内部控制自我评价报告的核查意见

Landfar Bio-medicine: Western Securities Co., Ltd. inspection opinions on the 2023 internal control self-evaluation report of Nanhua Biopharmaceutical Co., Ltd.

Sensex a share ·  Apr 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more